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ward a myofibroblast phenotype in CD248 –/– mice. CD248 –/–
 fibroblasts also proliferated less and deposited less collagen 
in vitro.  Conclusion: These studies suggest that CD248 stro-
mal cells have a pathogenic role in renal fibrosis and that 
targeting CD248 is effective at inhibiting both microvascular 
rarefaction and renal fibrosis through modulation of peri-
cyte and stromal cell function.  © 2015 The Author(s)
Published by S. Karger AG, Basel 
 Introduction 
 Tissue fibrosis and microvascular rarefaction are the 
pathological hallmarks of progressive end-stage renal dis-
ease  [1, 2] . It has recently been established that resident 
microvascular pericytes and perivascular fibroblasts are 
the predominant source of the activated, matrix deposit-
ing stromal cell population in fibrotic kidney tissue  [3–5] . 
However, there are currently no therapeutic strategies 
that directly target these disease processes. It has been es-
tablished that pericyte activation leads to detachment 
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 Abstract 
 Background: Tissue fibrosis and microvascular rarefaction 
are hallmarks of progressive renal disease. CD248 is a trans-
membrane glycoprotein expressed by key effector cells 
within the stroma of fibrotic kidneys including pericytes, 
myofibroblasts and stromal fibroblasts. In human disease, in-
creased expression of CD248 by stromal cells predicts pro-
gression to end-stage renal failure. We therefore, hypothe-
sized that the genetic deletion of the  CD248 gene would pro-
tect against fibrosis following kidney injury.  Methods: Using 
the unilateral ureteral obstruction (UUO) model of renal fi-
brosis, we investigated the effect of genetic deletion of 
 CD248 on post obstructive kidney fibrosis.  Results: CD248 
null mice were protected from fibrosis and microvascular 
rarefaction following UUO. Although the precise mechanism 
is not known, this may to be due to a stabilizing effect of peri-
cytes with less migration and differentiation of pericytes to-
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from the vasculature, migration and differentiation into 
the scar-forming myofibroblasts within the tubulointer-
stitium. This leads to destabilization of vascular integrity, 
microvascular rarefaction and tissue hypoxia  [6, 7] . The 
histological evidence of these disease processes (vessel 
rarefaction and the extent of tubulointerstitial fibrosis) 
within kidney biopsy tissue is known to correlate with 
poor prognostic outcomes in patients with CKD  [2, 7, 8] . 
In view of the key effector roles of pericytes, perivascular 
fibroblasts and myofibroblasts, identification and func-
tional characterization of novel proteins expressed by 
these resident cell types will be critical for the therapeutic 
modulation of these disease pathways.
 CD248 (endosialin) is a type I transmembrane glyco-
protein that is expressed by stromal fibroblasts, myofi-
broblasts and a subset of pericytes, but not by endothelial 
cells  [9–12] . Upregulated expression of CD248 has been 
observed following inflammation, and the constitutive 
loss of CD248 has been shown to modulate inflammatory 
tissue stroma  [13–15] . The function of CD248 has not 
been fully elucidated; however, it has been shown to reg-
ulate platelet-derived growth factor (PDGF) receptor 
(PGDFR) signaling and bind fibronectin and collagens 
types I and IV  [16] . Binding of these ligands is thought to 
mediate stromal cell adhesion, migration and prolifera-
tion in vitro  [17] .
 We have previously demonstrated in kidney biopsy 
tissue that  CD248 is expressed by mesangial pericytes of 
the glomerulus, and expressed at low levels by a popula-
tion of peritubular cells that morphologically resemble 
pericytes  [10] .  CD248 expression was upregulated in stro-
mal compartment of fibrotic kidneys being expressed by 
stromal fibroblasts and tissue myofibroblasts. The level of 
expression correlated with progression of renal disease. 
We thus hypothesised that  CD248 -expressing stromal 
cells are pathogenic in renal fibrosis. To test our hypoth-
esis, we have induced renal fibrosis using the unilateral 
ureteral obstruction (UUO) model of kidney injury in 
CD248 –/– mice. We demonstrate that CD248 –/– mice are 
protected against myofibroblast accumulation, microvas-
cular rarefaction and renal fibrosis.
 Materials and Methods 
 Mice and Surgery 
 129SvEv mice were purchased from Taconic, Denmark and 
maintained in 12-hour light/12-hour dark cycle with free access to 
food and water. All procedures were performed in accordance with 
UK Home Office guidelines. Transgenic mice lacking CD248 –/– 
were generated and genotyped as previously described  [18] . For all 
in vivo studies, 6 litter-matched male mice aged 8–10 weeks were 
used in each experimental group. Experiments were repeated 
3 imes in independent experiments. Bone marrow chimeras were 
generated as previously described  [19] using fetal liver cells ex-
pressing enhanced yellow fluorescent protein under the control of 
the Rosa26 promoter. Unilateral ureteric obstruction was per-
formed by midline laparotomy; in brief, the left ureter was identi-
fied and ligated at 2 points. Sham-operated control mice under-
went an identical procedure except that the left ureter was mobi-
lized but not ligated. For all in vivo studies, 6 litter-matched male 
mice aged 8–10 weeks were used in each experimental group. Ex-
periments were repeated 3 times in independent experiments.
 Immunohistochemistry 
 Four-micrometer tissue paraffin sections were dewaxed in xy-
lene and re-hydrated. Antigen retrieval was performed using Dako 
Target Antigen Retrieval solution (Dako) at 95   °   C. Sections were 
stained according to the Dako rabbit Envision-HRP kit protocol. 
Sections were then counterstained with Mayer’s hematoxylin. Rab-
bit anti-mouse CD248 unconjugated (clone PI3, in house antibody) 
was used to localize  CD248 expression  [12] . Isotype controls were 
substituted for primary antibody on serial sections. Renal fibrosis 
was visualized and quantified with use of Picrosirius red stain. 
Twelve non-overlapping fields at ×400 magnification from each 
section were captured using a Nikon Eclipse E400 microscope and 
digital camera (Nikon). The threshold of pixels was expressed as a 
percentage of the total pixels using Adobe Photoshop. This was tak-
en to represent the percentage area staining positively for collagen.
 Confocal Microscopy 
 The following were the primary antibodies: rat anti-mouse 
CD45 (eBioscience), rat anti-mouse PDGFRβ biotin (1: 100; eBio-
science, USA; clone APB5), anti-mouse alpha SMA (clone 1A4, 
Sigma), hamster anti-CD31 (1: 100; Serotec, BioRad, USA; clone 
2H8), anti-CD248 (1: 400; clone p13, gift from Claire Isacke, The 
Institute of Cancer Research, London, UK), anti-NG2 (1: 75; Up-
state, Merck Millipore, USA; clone 132.38), mouse anti-desmin 
(Dako, 1: 100). Primary antibodies were detected using appropri-
ately conjugated secondary antibodies. DAPI was used as a nucle-
ar counterstain.
 For quantification, specific cells were counted in randomly se-
lected fields of view at ×400 or ×630 magnification per mouse tis-
sue section. Twenty-five random fields of view were analyzed per 
tissue section in 3 independent experiments. A cell was recorded 
as positive if 75% of the cell area immediately surrounding nuclei 
stained positive. A Zeiss confocal LSM 510 microscope (Zeiss, 
 Germany) was used to visualize staining with images and captured 
and processed using the Zeiss LSM Image Examiner software 
(Zeiss). Representative images were chosen from each experiment 
for figure editing. For microvascular studies, quantification of the 
number of fluorescence pixels was calculated using Adobe Photo-
shop. The percentage area per field covered by vessels (positive 
CY-3 immunofluorescence) was then expressed as a percentage of 
the total pixel count. Results were expressed as mean ± SEM of 10 
fields of view per mouse tissue section.
 Western Blotting 
 Tissue was homogenized in CellLyticMT (Sigma) sample buf-
fer as per the manufacturer’s instructions. Protein content was 
quantified using the Bradford assay (BioRad). Equivalent amounts 
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of protein were loaded onto a 10% w/v non-denaturing SDS-PAGE 
gel. Gels were transferred onto PVDF membrane (GE Healthcare) 
and incubated with the primary antibodies: rabbit anti-mouse 
CD248 (clone PI3  [9] ) or with anti-mouse GAPDH (Abcam) fol-
lowed by horseradish peroxidase-conjugated anti-rabbit IgG (Am-
ersham, Buckinghamshire, UK). Immunodetection was carried 
out using an enhanced chemiluminescence kit (Amersham, Buck-
inghamshire, UK) followed by exposure to X-ray film.
 Quantitative Polymerase Chain Reaction 
 RNA was extracted using an RNeasy kit (Qiagen) and tran-
scribed into cDNA using a TaqMan ® Reverse Transcription (Ap-
plied Biosystems) kit as per the manufacturer’s instructions. Quan-
titative PCR was performed using TaqMan Gene Expression assays; 
 CD248 (Mm00547485),  Collagen 1A1 (Col1a1; Mm00801666) and 
 GAPDH (4352339E) were used as a housekeeping gene. Assays 
were run on a 7900HT Real Time PCR System (Applied Biosys-
tems). CT values were normalized using  GAPDH as a housekeeping 
gene (ΔCT). Fold changes in gene expression were then calculated 
using 2 –ΔΔCT .
 Isolation of Renal Cells 
 Renal cell populations were isolated from murine kidney using 
the Dynabead infusion method described by Takemoto et al.  [20] . 
The kidneys were then harvested, minced and a digested with col-
lagenase IV 10 mg/ml in Hank’s buffer with 200 U/ml DNase I 
(Roche) for 30 min at 37   °   C. The glomeruli were then separated 
from the tubules using a magnet (Invitrogen). Glomeruli were 
plated in RPMI 1640 (Gibco) containing 20% fetal calf serum (Gib-
co), 1.75 m M glutamine, 87 U/ml penicillin, 87 μg/ml streptomy-
cin, 15 m M HEPES and 1 m M sodium pyruvate (all from Gibco) 
for the outgrowth of mesangial cells; tubules were plated in 
DMEM/F12 (Gibco) containing 20% fetal calf serum, 1.75 m M glu-
tamine, 87 U/ml penicillin, 87 μg/ml streptomycin for the out-
growth of renal fibroblasts or in DMEM/F12 (Gibco) containing 
0.5% fetal calf serum, 1.75 m M glutamine, 87 U/ml penicillin, 87 
μg/ml streptomycin, 10 μg/ml insulin, 5.5 μg/ml transferrin, 5 ng/
ml sodium selenite, 1 ng/ml endothelial growth factor (Sigma UK), 
5 pg/ml triiodothyronine, 5 μg/ml dexamethasone and 2.5 μg/ml 
amphotericin (all from Gibco) for the isolation of proximal tubular 
epithelial cells. Cell identity was confirmed by morphology and 
expression of cell-specific markers. All cell cultures were grown 
through multiple passages (passage 4) to ensure homogeneity. All 
cells were negative for CD45, CD31 and podocyte marker, synap-
topodin. Mesangial pericytes and tubulointerstitial fibroblasts 
were positive for CD90, fibronectin and vimentin but negative for 
the epith.
 Functional Studies 
 Eight thousand cells were seeded per well in a 96-well plate 
(counted using a Beckman Coulter Counter). Cells were serum 
starved for 24 h (media replaced with complete media in the ab-
sence of serum). Serum media was replaced at 24 h and MTT 
(MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) assay was then performed according to manufacturer’s in-
structions (Life Technologies). Crystal violet staining was used in 
parallel to ensure that the increased MTT activity correlated with 
an increase in cell number. A Picrosirius red dye-binding assay 
originally described by Heng et al.  [21] was used for measuring 
collagen accumulation in vitro.
 Statistical Analysis 
 Results are presented as means ± SEM. The statistical signifi-
cance of differences between means was assessed using 1-way or 
2-way analysis of variance (ANOVA) with appropriate post-test 
analysis or 2-tailed Student’s t test. Values of p < 0.05 were consid-
ered significant. Analysis and graphs were prepared using Prism 5 
(GraphPad, San Diego, Calif., USA).
 Results 
 CD248 Is Expressed in Adult Murine Kidney by a 
Subset of Pericytes and Perivascular Fibroblasts and 
Upregulated in the Tissue Stroma of Inflamed Kidneys 
 Consistent with our previous observations  [10] , we 
found CD248 was expressed by a subset of peritubular 
cells within the stromal compartment of resting murine 
kidney ( fig. 1 A). The close proximity of these cells to the 
vasculature suggested that  CD248 might be expressed by 
a subset of vascular pericytes. We identified pericytes his-
tologically with a panel of antibodies against PDGFRβ, 
NG2, αSMA and desmin and expression was seen to co-
localize with a subset of pericytes identified by these an-
tibodies ( fig. 1 A). In kidney tissue from both wild type 
(WT) and CD248 –/– mice between 62 and 95% of CD31-
positive vessels within the tissue were associated with 
pericyte cell bodies or processes ( fig. 1 B) depending on 
the pericyte marker that was used. The pericyte coverage 
of kidney endothelium is consistent with the observations 
of previous studies  [22] . CD248 was visible on some of 
these pericytes and also occasionally on cells where none 
of the 3 other pericyte markers used were detectable 
( fig.  1 ). There were no significant differences between 
pericyte coverage ( fig. 1 B), or expression of each pericyte 
marker in tissue from CD248 –/– compared to WT mice 
( fig. 1 B). As expected,  CD248 expression on pericytes was 
not expressed in CD248 –/– kidney tissue ( fig. 1 B).
 Renal fibrosis was induced using the UUO model of 
renal fibrosis as previously described  [23] . In this model, 
ligation of the ureter leads to an obstructive nephropathy 
and progressive tissue fibrosis. Kidney tissue was harvest-
ed and digested at 3, 7 and 14 days following UUO and 
from sham-operated mice. Following UUO, CD248 
mRNA expression was found to be significantly increased 
at 7 and 14 days post UUO ( fig. 2 A), and this increased 
expression was also confirmed at the protein level ( fig. 2 B). 
Using immunohistochemistry, we observed that the up-
regulated expression of  CD248 occurred within the stro-
mal compartment of the kidney with CD248 being high-
ly expressed by vascular pericytes and stromal fibroblasts/
myofibroblasts ( fig.  2 C). In contrast, in sham-operated 
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 Fig. 1.  CD248 is expressed by a subset of pericytes resting kidney. 
 A CD248 co-localized with recognized markers of pericytes in rest-
ing kidney. Representative images are shown at ×630 magnifica-
tion of WT resting kidney (right panel) with high-powered images 
(2 × zoom of ×630 original magnification) on the left panel stained 
with CD31 (endothelium, red), CD248 (blue) and pericyte mark-
ers: NG2, αSMA, PDGFRβ and desmin (green). Scale bar 50 μm. 
 *   Indicates an example of cell staining positive for both CD248 
(blue) and the pericyte marker (green).  B Expression of individual 
pericyte markers, expressed as percentage of CD31 positive vessels 
positive for PDGFRβ, NG2, αSMA or desmin. Filled bars are WT 
and open bars are CD248 –/– . Data presented are mean ± SEM from 
10 high-powered (×630) fields of view per mouse kidney section 
(10 × kidney sections were analyzed from 6 individual mouse). 
N.E. = Not expressed. 
 Fig. 2.  CD248 expression increases following unilateral ureteric ob-
struction. Expression of CD248 was examined by quantitative PCR 
on whole kidneys ( A ). Results are expressed as mRNA fold change 
mean ± SEM relative to the control group (sham operated day 14; 
1-way ANOVA with Bonferroni’s post test relative to control,  *  p < 
0.01,  * *  p < 0.001, n = 6 mice per treatment group).  B Whole kidney 
lysates were also used to demonstrate CD248 protein expression at 
baseline (no operation performed), following a sham operation on 
day 14 and after UUO for 3, 7 and 14 days.  Ca ,  b Tissue histology 
of sham-operated kidney tissue showed  CD248 was expressed by 
mesangial cells of the glomerulus (arrow) and by peritubular 
cells ( * ). At 14 days following UUO,  tubular dilatation and intersti-
tial expansion accompanied increased  CD248 expression in the in-
terstitium ( * ) in a space expected to be occupied by pericytes and 
stromal fibroblasts ( Cc ,  d ). Magnification ×20 ( Ca ,  c ) and ×63 ( Cb , 
 d ).  D Bone marrow chimera studies. UUO-injured tissue from day 
14 is shown. Yellow fluorescent protein (green) is expressed in the 
cytoplasm of infiltrating cells many of which are CD45+ leucocytes 
(red) but not within resident CD248+ stromal cells (blue). Magni-
fication ×40 (representative images from n = 8 chimeric mice gen-
erated). Scale bar 50 μm. 
(For figure see next page.)
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6
kidney tissue,  CD248 expression was low and restricted 
to a small number of vascular pericytes and mesangial 
cells of the glomerulus. We next performed bone marrow 
chimera studies to confirm that following UUO, CD248 
was expressed only by resident stromal cells and not by 
infiltrating (donor derived) bone marrow-derived cells 
( fig. 2 D).
 CD248 –/– Mice Are Protected against the Development 
of Renal Fibrosis Following UUO 
 To examine the role of CD248 in renal fibrosis, we per-
formed UUO in CD248 –/– mice. At baseline, there was no 
significant difference in body weight, urinary protein 
loss, renal function or the histological appearance of the 
tubulointerstitial space and glomerular compartments 
between WT and CD248 –/– mice (p > 0.05, ns, n = 10 mice 
per group, data not shown). Following UUO, the severity 
of renal fibrosis was determined by histological examina-
tion for collagen deposition using Sirius red stain. There 
was a significant increase in the deposition of fibrillary 
collagen in the tubulointerstitial space 7 and 14 days post 
UUO ( * * * p  ≤ 0.001) compared to sham-operated mice in 
both WT and CD248 –/– mice. However, CD248 –/– mice 
deposited significantly less collagen after 14 days of UUO 
(42% reduction,  * * p < 0.01) compared to WT mice. Sim-
ilarly, collagen 1a1 (Col1a1) mRNA transcription was 
significantly increased 7 and 14 days following injury 
compared to sham-operated tissue. In CD248 –/– mice, 
 col1a1 RNA expression was increased in response to in-
jury ( * p < 0.01) but levels were blunted compared to WT 
mice, and there was no significant difference in expres-
sion at days 3, 7 and 14 post UUO. Col1a1 RNA expres-
sion was significantly reduced in CD248 –/– mice at day 14 
following injury compared to WT mice ( * * p < 0.01).
 To determine if CD248 –/– mice were protected from 
renal fibrosis as a result of a change in leucocyte accumu-
lation within the tissue, we examined the numbers of 
CD45, CD3 and F4/80 expressing leucocytes in kidney 
tissue using confocal microscopy. Following UUO, there 
was a progressive infiltration of leukocytes in fibrotic kid-
ney tissue but no significant difference in the number of 
infiltrating leucocyte populations in CD248 –/– mice com-
pared to WT mice ( fig. 3 E).
 Pericyte Attachment in Response to Renal Injury 
 Vascular pericytes have been shown to migrate into 
the kidney tissue stroma and differentiate into myofi-
broblasts following injury  [6] . As  CD248 was found to 
be highly expressed by a subpopulation of pericytes 
 during inflammation, we next determined whether 
CD248 –/– mice were protected from renal fibrosis as a 
result of having less tissue myofibroblasts. Following re-
nal injury in WT mice, the number of interstitial myo-
fibroblasts as marked by αSMA was significantly in-
creased 7 and 14 days post UUO compared to sham-
operated mice ( * * p  ≤ 0.001). In contrast, there was no 
statistically significant increase in αSMA cells in follow-
ing UUO in CD248 –/– mice compared to sham-operated 
animals ( fig. 4 ).
 We next determined whether the reduction in myofi-
broblast number correlated with a change in the numbers 
of vascular pericytes in the kidneys of CD248 –/– mice fol-
lowing UUO. NG2 staining was used to identify vascular 
pericytes, and attachment of pericytes to endothelium 
was defined by adjacent staining of the pericyte marker 
with CD31 (>50% cell contact). In sham-operated mice, 
kidney pericytes were found in association with 62 (±23%) 
of blood vessels ( fig. 5 Aa) but following injury, less peri-
cytes were seen in close apposition with endothelial cells 
at day 7 ( fig. 5 Ab) and day 14 ( fig. 5 Ac) following UUO. 
In WT mice 14 days post UUO, the percentage of peri-
cytes in the stromal tissue increased, and less pericytes 
were seen closely attached to endothelium ( fig. 5 Ad). In 
comparison, the percentage of pericytes was less in kid-
ney tissue from CD248 –/– mice 14 days following UUO 
and most were seen in close association with endothelium 
( fig. 5 Ae).
 These findings were confirmed by quantification of 
pericyte number and the number of pericytes in close as-
sociation with CD31+ cells in WT and CD248 –/– kidney 
tissue following UUO. Following UUO, the number of 
NG2-positive pericytes were significantly increased 
in both WT and CD248 –/– mice at days 3 ( * p  ≤ 0.05), 7 and 
14 (Ψ p  ≤ 0.01) post injury compared to sham-operated 
mice ( fig. 5 B). However, the magnitude of the increase in 
pericytes was significantly less in CD248 –/– mice. At day 3, 
there was no significant difference in the percentage of 
NG2-positive cells between WT and CD248 –/– mice but at 
days 7 and 14, the number of NG2-positive cells was sig-
nificantly greater in WT mice compared to CD248 –/– mice 
(p  ≤ 0.01). In WT mice, there was a specific expansion in 
CD248+ NG2+ cells 7 days ( * * p  ≤ 0.01) and 14 days 
( * *  p  ≤ 0.01) post UUO compared to sham-operated mice. 
Finally, the number of pericytes in close association with 
endothelium (defined by >50% of pericyte in contact with 
CD31+ cells) was significantly reduced at day 7 ( *  p  ≤ 0.05) 
and day 14 ( * * p  ≤ 0.01) post UUO in WT mice compared 
to sham-operated mice. In contrast, no significant differ-
ence was observed in CD248 –/– mice post UUO compared 
to sham-operated mice.
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 CD248 –/– Mice Are Protected from Microvascular 
Rarefaction Following UUO 
 Prior to injury, there was no difference in vessel area 
between WT and CD248 –/– animals ( fig. 6 B). Following 
injury, there was an initial increase in vessel density in 
WT mice 3 days post injury followed by progressive vas-
cular regression 14 days post injury ( fig. 6 B) suggesting 
an early phase of reparative angiogenesis followed by vas-
cular regression (microvascular rarefaction), as previous-
ly reported  [6] . In contrast, CD248 –/– mice did not have 
an early phase of reparative angiogenesis and were pro-
tected from microvascular rarefaction in response to in-
jury as no significant difference in CD31 area could be 
detected between sham-operated animals and day 14 in-
jured mice ( fig. 6 B far right panel).
 CD248 –/– Stromal Cells Exhibit Impaired Function in 
vitro 
 In order to determine whether the effects we observed 
in vivo were due to a direct effect of  CD248 expression 
on stromal compartment in the kidney, we isolated stro-
mal fibroblasts, mesangial cells, both of which express 
 CD248 , and as a control, we isolated proximal tubular 
epithelial cells, which do not express  CD248 . These cells 
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8
were isolated from WT and CD248 –/– mice. The prima-
ry cells were isolated and the homogeneity of cell cul-
tures confirmed as described in the methods. Fibroblasts 
and mesangial cells, but not proximal tubular epithelial 
cells isolated from CD248 –/– mouse kidneys exhibited a 
significantly reduced proliferative potential compared 
to cells isolated from WT mice ( fig. 6 C). Similarly, fibro-
blasts and mesangial cells, but not proximal tubular ep-
ithelial cells isolated from CD248 –/– mice exhibited a re-
duced capacity to deposit collagen in vitro ( fig.  6 D). 
These results suggest that the absence of CD248 can 
have a direct effect on the function of stromal cells in 
vitro.
 Discussion 
 In the present study, we demonstrate a pathogenic role 
for CD248 in the development of renal fibrosis. We show 
that  CD248 -deficient mice are protected from renal fibro-
 Fig. 3.  CD248 –/– mice accumulate less interstitial collagen than 
WT mice following unilateral ureteric obstruction despite no 
significant difference in leukocyte infiltration.  D Representative 
confocal images of leucocyte infiltration defined by the expres-
sion of CD45 (red), nuclear stain (blue) in kidney tissue sections 
from WT and CD248 –/– mice undergoing UUO. Magnification 
×40. Scale bar 50 μm.  E Digital quantification of CD45, CD3 and 
F4/80 expression in kidney tissue sections from WT and  CD248 –/– 
mice following UUO. Data are expressed as mean ± SEM per-
centage of positive cells in 10 random fields of view per kidney 
section at a magnification of ×40 in 3 independent experiments 
(total n = 30 images analyzed). No significant difference in leu-
cocyte infiltration was observed between WT and CD248 –/– 
mice. 
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9
sis and microvascular rarefaction. These observations 
build on our previous work showing an upregulation of 
CD248 within the kidney biopsies of patients with pro-
gressive fibrotic renal disease. Collectively our findings 
suggest that targeting CD248 may be an effective thera-
peutic strategy to inhibit tissue fibrosis and microvascular 
rarefaction through modulation of both pericyte and 
stromal cell function.
 Whilst the exact mechanism by which  CD248 -express-
ing stromal cells contribute to fibrosis is not yet fully 
known, we found that in the absence of CD248, more vas-
cular pericytes remain associated with the vascular endo-
thelium and fewer matrix depositing myofibroblasts are 
seen in tubulointerstitium. These observations are con-
sistent with recent reports establishing that the primary 
source of matrix depositing stromal cells are pericytes 
that migrate from the endothelium to the stromal com-
partment resulting in vascular instability  [6] . Our find-
ings suggest that  CD248 expression on stromal cells and 
pericytes is a critical step in regulating the effective op-
eration of these 2 disease processes.
 We have previously demonstrated that in resting kid-
ney,  CD248 is expressed by mesangial pericytes of the 
glomerulus and at low levels by a population of peritubu-
lar cells that morphologically appeared to represent peri-
cytes  [10] . With progressive renal fibrosis, upregulated 
expression of  CD248 was observed within the stromal cell 
compartment of the kidney. In the murine kidney,  CD248 
is expressed by mesangial cells of the glomerulus, stromal 
fibroblasts and some, but not all, pericytes surrounding 
the capillaries. PDGFRβ, NG2, αSMA and desmin are all 
widely used as pericyte markers, but none are specific for 
pericytes, nor expressed on all pericytes at all times  [24] . 
While CD248 sometimes co-localized with PDGFRβ, 
NG2 and desmin, CD31-positive capillaries were also 
seen closely surrounded by CD248 single-positive peri-
vascular cells, in a location expected to be occupied by 
pericytes. This suggests that CD248 can be useful in iden-
tifying a pericyte subset not detected by traditional peri-
cyte markers. We have recently reported similar findings 
in skeletal muscle where  CD248 is expressed by a subset 
of pericytes expressing traditional pericyte markers and a 
subset expressing only  CD248  [25] . Understanding the 
function and phenotype of these  CD248 -expressing peri-
cytes is the subject of ongoing work.
 In human disease, fibrosis and vascular rarefaction 
have consistently been reported to associate with a poor-
er disease outcome  [7] . Renal tubulointerstitial pericytes 
have been implicated in the development of renal fibrosis 
 [2, 3, 6] . Careful tracking and kinetic modeling studies 
performed by Lin et al. [6] have demonstrated that in re-
sponse to injury, Col1a1+ pericytes, which express 
PDGFRβ and αSMA, detach and migrate away from the 
underlying endothelium to form myofibroblasts that de-
posit collagen. This process is accompanied by microvas-
cular rarefaction with loss of pericytes from the vascula-
 Fig. 4. CD248 –/– mice have fewer αSMA+ myofibroblasts. Images 
showing αSMA expression (red) in injured kidney (14 days post 
UUO) in both WT and CD248 –/– cells. Nuclei blue. Magnification 
×630. Scale bar 50 μm. In WT mice, there was a significant increase 
in the number of αSMA+ cells at 7 and 14 days following injury 
compared to sham-operated mice (1-way ANOVA and post hoc, 
n = 6 mice per time point,  * *  p < 0.001). In contrast, the increase 
in αSMA+ cells was not observed in CD248 –/– mice. 
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10
 Fig. 5. Less pericytes are seen in association with endothelium and 
in the kidney interstitium in CD248 –/– mice following UUO. Rep-
resentative immunostaining for CD31 (red), CD248 (white), NG2 
(green) and nuclei blue ( A ) from sham-operated mice ( Aa ), WT 
mice 7 days ( Ab ) and 14 days ( Ac ) post UUO ×630 magnification. 
White arrows indicate pericytes not closely associated with endo-
thelium. WT ( Ad ) and CD248 –/– ( Ae ) kidney tissue 14 days post 
UUO (×400 magnification).  B Quantification of NG2 positive fi-
broblasts in WT vs. CD248 –/– mice and NG2+ CD248+ pericytes 
in WT kidney tissue following injury. Data are presented as mean ± 
SEM for percentage of positive cells per field of view (10 random 
fields of view at ×400 magnification selected per treatment group 
in 3 independent experiments, n = 6 mice per treatment group). 
The percentage of cells expressing NG2 in kidney tissue of both 
WT and CD248 –/– mice was significantly increased 3 days ( *  p = 
0.05), 7 and 14 days following UUO (Ψ p  ≤ 0.01). The percentage 
of NG2+ cells in WT mice was significantly ( * *  p  ≤ 0.01) increased 
in kidney tissue from WT vs. CD248 –/– mice at 7 and 14 days post 
UUO. The percentage of NG2 cells attached to endothelium (de-
fined as co-localization with CD31) was also quantified. In WT 
mice the percentage of NG2+ CD248+ were significantly increased 
( * *  p  ≤ 0.01) 7 and 14 days post injury compared to sham-operat-
ed mice. There was a significant increase in the number of pericytes 
(NG2-expressing cells) attached to the endothelium at 7 and 14 
days post UUO in CD248 –/– mice compared to WT mice ( *  p  ≤ 
0.01,  * *  p  ≤ 0.05). 
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ture and a failure of reparative angiogenesis  [6] . In addi-
tion, pericyte proliferation has been shown to be 
associated with both ischemic-reperfusion and UUO 
mouse models of renal fibrosis  [6, 26] . However, we do 
not yet know if the reduced number of myofibroblasts 
and pericytes in the stroma in  CD248 -deficient mice is the 
result of impaired migration or a specific defect in prolif-
eration in vivo.
 In the UUO model, an early angiogenic response to 
injury has been demonstrated with increased capillary 
density detected from day 2 (inflammatory angiogenesis) 
followed by microvascular rarefaction  [6] . In the absence 
of CD248, we observed that pericytes remain associated 
with the vascular endothelium and these kidneys are pro-
tected from vessel loss in response to injury. There is also 
blunting of the early angiogenic response to injury (lack 
of increase in vessel density at day 3). CD248-deficient 
mice also developed less stromal fibrosis following UUO. 
It has been demonstrated in cancer studies that CD248 
expression is associated with tumor progression and me-
tastasis  [27] . CD248 binds to extracellular matrix proteins 
fibronectin, collagens types I and IV, and it is thought that 
the interaction between these components and CD248 
mediates cell attachment and migration during tumor 
progression  [17, 28] . In the kidney, the absence of CD248 
may prevent the interaction between pericytes, ECM pro-
teins and stromal fibroblasts and prevent these cells from 
migrating from the vasculature into the tissue stroma and 
differentiating into myofibroblasts. This in turn would 
result in less stromal fibrosis following renal injury and 
stabilization of the vasculature preventing microvascular 
refraction.
 PDGF signaling from endothelial cells to PDGFR on 
pericytes has been shown to be vital for vascular stabili-
zation following kidney injury  [22] . Recent evidence sug-
gests that CD248 may exert its effects through regulation 
of the PDGF pathway as PDGF-induced phosphoryla-
tion of extracellular signal-regulated kinase (ERK), but 
not phosphorylation of PDGFR itself, was markedly di-
minished in CD248-deficient pericytes  [16] . Thus, 
CD248 may modify PDGF signaling acting downstream 
of PDGFR but upstream of ERK1/2 by an as yet unknown 
mechanism. It is therefore possible that our observation 
that the absence of CD248 leads to less microvascular 
rarefaction and fibrosis following injury may be the re-
sult of defective PDGF pericyte signaling leading to de-
creased detachment from the endothelium in response to 
injury.
 Renal injury and inflammation following UUO re-
sult in increased expression of CD248 on fibroblasts 
within the kidney stroma. In resting kidney, these cells 
did not express  CD248 . This increased expression of 
 CD248 was seen in addition to the increased subset of 
pericytes expressing  CD248 following UUO. The high 
expression of  CD248 in stromal cells in inflamed tissue, 
with low expression in healthy tissue makes it is an ap-
pealing therapeutic target. Targeting single receptors on 
pericytes such as PDGFRβ is sufficient in some models 
to prevent fibrosis  [6, 22] . However, pericyte detach-
ment occurs early in the evolution of renal injury  [5], 
and therefore, blockade of CD248, which would lead to 
less pericyte detachment, is an attractive therapeutic 
candidate.
 Our findings suggest that the constitutive removal of 
CD248 modulates the response of renal pericytes and 
stromal fibroblasts to injury. Although the precise mech-
anism is not yet known, it is clear that genetic loss of 
CD248 significantly reduces the formation of matrix de-
positing myofibroblasts in response to renal injury by 
ureteric obstruction, resulting in less tissue fibrosis. Our 
data highlight CD248 as a novel, anti-fibrotic, target with 
the added advantage that it may allow for the modulation 
of both activated pericytes and fibroblasts but not epithe-
lial cells found in inflamed but not normal tissue. Target-
ing CD248 expressing stromal cells has the capability 
to  modulate both microvascular rarefaction and tissue 
fibrosis, 2 vital disease processes in progressive renal 
 fibrosis.
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